• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介绍CRAFT:碎片与分子靶点研究与进展中心。

Introducing CRAFT: The Center for Research and Advancement in Fragments and molecular Targets.

作者信息

Andrade Carolina Horta, Nonato Maria Cristina, da Silva Emery Flavio

机构信息

Center for Research and Advancement in Fragments and Molecular Targets (CRAFT), School of Pharmaceutical Sciences at Ribeirao Preto, University of São Paulo, Ribeirão Preto, São Paulo 05508-060, Brazil.

Laboratory for Molecular Modeling and Drug Design (LabMol), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, Goiás 74605-170, Brazil.

出版信息

ACS Med Chem Lett. 2024 Jul 23;15(8):1174-1177. doi: 10.1021/acsmedchemlett.4c00296. eCollection 2024 Aug 8.

DOI:10.1021/acsmedchemlett.4c00296
PMID:39140068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318094/
Abstract

We introduce the Center for Research and Advancement in Fragments and Molecular Targets (CRAFT), a pioneering research center established in 2021 through a collaboration between the University of São Paulo (USP) and the Federal University of Goiás (UFG). CRAFT integrates fragment-based drug discovery (FBDD), artificial intelligence (AI), and structural biology to develop novel therapeutic strategies. We have created fragment and target libraries and utilize AI models to streamline the drug discovery process. We invite the global scientific community to collaborate with us in addressing neglected diseases, with the goal of enhancing research capabilities and fostering scientific innovation across Latin America.

摘要

我们介绍碎片与分子靶点研究与推进中心(CRAFT),这是一个于2021年通过圣保罗大学(USP)和戈亚斯联邦大学(UFG)合作建立的开创性研究中心。CRAFT整合基于片段的药物发现(FBDD)、人工智能(AI)和结构生物学,以开发新的治疗策略。我们创建了片段和靶点库,并利用人工智能模型简化药物发现过程。我们邀请全球科学界与我们合作,共同应对被忽视的疾病,目标是提高整个拉丁美洲的研究能力,促进科学创新。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/11318094/9ed6d7fa7185/ml4c00296_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/11318094/9ed6d7fa7185/ml4c00296_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/770d/11318094/9ed6d7fa7185/ml4c00296_0001.jpg

相似文献

1
Introducing CRAFT: The Center for Research and Advancement in Fragments and molecular Targets.介绍CRAFT:碎片与分子靶点研究与进展中心。
ACS Med Chem Lett. 2024 Jul 23;15(8):1174-1177. doi: 10.1021/acsmedchemlett.4c00296. eCollection 2024 Aug 8.
2
Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.基于片段的药物发现策略:适用于多种靶点的策略
Curr Top Med Chem. 2021;21(13):1099-1112. doi: 10.2174/1568026621666210804115700.
3
The advancement of artificial intelligence in biomedical research and health innovation: challenges and opportunities in emerging economies.人工智能在生物医学研究和健康创新中的进步:新兴经济体面临的挑战和机遇。
Global Health. 2024 May 21;20(1):44. doi: 10.1186/s12992-024-01049-5.
4
Fragment-based drug discovery-the importance of high-quality molecule libraries.基于片段的药物发现——高质量分子库的重要性。
Mol Oncol. 2022 Nov;16(21):3761-3777. doi: 10.1002/1878-0261.13277. Epub 2022 Jul 10.
5
Introduction to fragment-based drug discovery.基于片段的药物发现简介。
Top Curr Chem. 2012;317:1-32. doi: 10.1007/128_2011_180.
6
Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.利用片段的 DNA 编码文库进行具有挑战性的治疗靶目标的命中发现。
Expert Opin Drug Discov. 2024 Jun;19(6):725-740. doi: 10.1080/17460441.2024.2354287. Epub 2024 May 16.
7
Establishing a Center for Innovation and Artificial Intelligence in a Tertiary Medical Center: Successes and Challenges.在一家三甲医院建立创新和人工智能中心:成功与挑战。
Isr Med Assoc J. 2024 Feb;26(2):74-79.
8
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
9
Fragment informatics and computational fragment-based drug design: an overview and update.片段信息学和基于片段的计算药物设计:概述和更新。
Med Res Rev. 2013 May;33(3):554-98. doi: 10.1002/med.21255. Epub 2012 Mar 19.
10
Virtual fragment preparation for computational fragment-based drug design.用于基于计算片段的药物设计的虚拟片段制备
Methods Mol Biol. 2015;1289:31-41. doi: 10.1007/978-1-4939-2486-8_4.

引用本文的文献

1
Fragment Libraries from Large and Novel Synthetic Compounds and Natural Products: A Comparative Chemoinformatic Analysis.来自大型新型合成化合物和天然产物的片段库:比较化学信息学分析
ACS Omega. 2025 Apr 16;10(16):16921-16937. doi: 10.1021/acsomega.5c01420. eCollection 2025 Apr 29.

本文引用的文献

1
Forging a Future Free from Neglected Tropical Diseases.打造一个无被忽视热带病的未来。
ACS Med Chem Lett. 2024 Feb 26;15(3):314-315. doi: 10.1021/acsmedchemlett.4c00060. eCollection 2024 Mar 14.
2
Unveiling the Antiviral Capabilities of Targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2.揭示靶向人类二氢乳清酸脱氢酶对严重急性呼吸综合征冠状病毒2的抗病毒能力。
ACS Omega. 2024 Feb 28;9(10):11418-11430. doi: 10.1021/acsomega.3c07845. eCollection 2024 Mar 12.
3
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
4
Synthesis and vectorial functionalisation of pyrazolo[3,4-]pyridines.吡唑并[3,4 -]吡啶的合成与矢量官能化
RSC Adv. 2023 Nov 23;13(49):34391-34399. doi: 10.1039/d3ra07458g. eCollection 2023 Nov 22.
5
Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.通过开放科学合作项目 OpenZika 发现新的 Zika 蛋白酶和聚合酶抑制剂。
J Chem Inf Model. 2022 Dec 26;62(24):6825-6843. doi: 10.1021/acs.jcim.2c00596. Epub 2022 Oct 14.
6
Growth vector elaboration of fragments: regioselective functionalization of 5-hydroxy-6-azaindazole and 3-hydroxy-2,6-naphthyridine.片段的生长向量阐述:5-羟基-6-氮杂吲哚和 3-羟基-2,6-萘啶的区域选择性功能化。
Org Biomol Chem. 2022 Sep 28;20(37):7483-7490. doi: 10.1039/d2ob00968d.
7
Trypanosoma cruzi nitroreductase: Structural features and interaction with biological membranes.克氏锥虫硝基还原酶:结构特征与生物膜相互作用。
Int J Biol Macromol. 2022 Nov 30;221:891-899. doi: 10.1016/j.ijbiomac.2022.09.073. Epub 2022 Sep 11.
8
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors.计算和实验方法确定β受体阻滞剂为潜在的SARS-CoV-2刺突蛋白抑制剂。
ACS Omega. 2022 Aug 8;7(32):27950-27958. doi: 10.1021/acsomega.2c01707. eCollection 2022 Aug 16.
9
Characterization of class II fumarase from Schistosoma mansoni provides the molecular basis for selective inhibition.曼氏血吸虫 II 型延胡索酸酶的特性为选择性抑制提供了分子基础。
Int J Biol Macromol. 2021 Apr 1;175:406-421. doi: 10.1016/j.ijbiomac.2021.01.180. Epub 2021 Feb 4.
10
Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni.曼氏血吸虫二氢乳清酸脱氢酶的功能及抑制的结构基础。
FEBS J. 2021 Feb;288(3):930-944. doi: 10.1111/febs.15367. Epub 2020 Jun 7.